| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 10/28/2004 | WO2003082317A9 Peptide epitopes recognized by antigen specific cd8+ t lymphocytes |
| 10/28/2004 | WO2003072600A8 Methods of screening molecular libraries for active molecules that restore the function of target proteins and peptides that restore the function of mutant p53 |
| 10/28/2004 | WO2003052064A3 Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media |
| 10/28/2004 | WO2003022991A3 Compositions and methods of use of targeting peptides against placenta and adipose tissues |
| 10/28/2004 | US20040214846 A heteroaryl carbamic acid, secondary amide or amine, or phthalimidoyl derivatives; prevent from getting the disease or condition; cognitive impairment, Down's syndrome, Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-Type, cerebral amyloid angiopathy, neurodegenerative disease |
| 10/28/2004 | US20040214776 (truncated GDNF) proteins that promote dopamine uptake by dopaminergic cells and promote the survival of nerve cells |
| 10/28/2004 | US20040214765 Methods and means for inhibition of CDK4 activity |
| 10/28/2004 | US20040214755 cyclic depsipeptides and/or mimetics, used as anticarcinogenic agents, formed by cyclization of polypeptides |
| 10/28/2004 | US20040214328 Multifunctional molecular complexes for gene transfer to cells |
| 10/28/2004 | US20040214256 Fluorescence detection of proteases or peptidases |
| 10/28/2004 | US20040214246 Monoclonal antibodies specific to pro-prostate specific antigen (PROPSA) for use as component of bioassy for detection of cancer |
| 10/28/2004 | US20040214206 Method of designing multifunctional base sequence |
| 10/28/2004 | US20040213799 Boosting priming composition with nonreplicating and/or replication impaired strains of poxvirus vectors; forming human immunodeficiency virus inhibitors |
| 10/28/2004 | CA2522076A1 Method for identifying modulators of g protein coupled receptor signaling |
| 10/27/2004 | EP1470249A2 Effectors of innate immunity |
| 10/27/2004 | EP1470224A1 Molecular libraries |
| 10/27/2004 | EP1470157A2 Novel peptide derivatives, preparation and therapeutic and cosmetic application thereof |
| 10/27/2004 | EP1470154A1 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof |
| 10/27/2004 | EP1470153A2 Two gonadotropin releasing hormones and a method to isolate the same |
| 10/27/2004 | EP1470152A1 Peptides for increasing transfection efficiency |
| 10/27/2004 | EP1469887A2 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 10/27/2004 | EP1469869A2 Peptide useful in immunomodulation |
| 10/27/2004 | EP1115739A4 Auxiliary for amide bond formation |
| 10/27/2004 | EP0918795B1 Antiangiogenic drug to treat cancer, arthritis and retinopathy |
| 10/27/2004 | EP0813544B1 Bradykinin antagonist peptides incorporating n-substituted glycines |
| 10/27/2004 | CN1541266A FCE fusion proteins for treatment of allergy and asthma |
| 10/27/2004 | CN1541102A Somatostain agonists |
| 10/26/2004 | US6809180 Compositions and methods for screening antimicrobials |
| 10/26/2004 | US6809177 Comprises catalytic reduction of hydroxyl groups to monodeoxy analogues; for conversion of mulundocandin/deoxymulundocandin |
| 10/26/2004 | US6809176 Compounds for use in treatment of cancer |
| 10/26/2004 | US6809077 A cyclic polypeptides; immunosuppressive anti-inflammatory activity, inhibiting antigen-induced inflammatory cell infiltration |
| 10/26/2004 | US6808877 Ligands for FPR class receptors that induce a host immune response to a pathogen or inhibit HIV infection |
| 10/21/2004 | WO2004090157A1 The use of pde4d in the screening for medicaments against atherosclerosis |
| 10/21/2004 | WO2004090103A2 Identification of novel nogo-receptors and methods related thereto |
| 10/21/2004 | WO2004089960A2 Process for preparation of cyclosporin “a” analogues having a terminal diene group |
| 10/21/2004 | WO2004089396A2 Anti-fungal peptidomimetics |
| 10/21/2004 | WO2004073650A3 Peptidomimetic inhibitors of stat3 activity and their medical uses |
| 10/21/2004 | WO2004062556A8 Methods for preventing and treating alzheimer’s disease (ad) |
| 10/21/2004 | WO2004056871A3 Peptides and their use for the treatment of hiv infections |
| 10/21/2004 | WO2004025243A3 A method for the identification of drug targets |
| 10/21/2004 | WO2003100081A3 Biologically active maleamic acid derivatives with labile amide bonds |
| 10/21/2004 | WO2003043631A3 Method for identification of tumor targeting enzymes |
| 10/21/2004 | WO2003010190A3 Peptide screen |
| 10/21/2004 | US20040210041 Multimeric proteins for use in the treatment and detection of cell proliferative disorders |
| 10/21/2004 | US20040209808 antiproliferative agents; monoclonal/polyclonal antibodies; drug screening; kits |
| 10/21/2004 | US20040209798 biodrugs for treatment of lung cancer, glioma, anorexia, hypothyroidism, hyperaldosteronism, H. pylori proliferation, acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites |
| 10/21/2004 | US20040209797 comprises protein transduction domains; nuclear localization sequences; fusion proteins; for reversible immortalization of cells |
| 10/21/2004 | US20040209282 Methods for producing polypeptide-tagged collections and capture systems containing the tagged polypeptides |
| 10/21/2004 | US20040208881 B1k chain of laminin and methods of use |
| 10/21/2004 | CA2521713A1 Anti-fungal peptidomimetics |
| 10/21/2004 | CA2521469A1 Identification of novel nogo-receptors and methods related thereto |
| 10/21/2004 | CA2521303A1 The use of pde4d in the screening for medicaments against atherosclerosis |
| 10/21/2004 | CA2521116A1 Process for preparation of cyclosporin "a" analogues having a terminal diene group |
| 10/20/2004 | EP1469010A1 Transcription regulatory gene and peptide |
| 10/20/2004 | EP1468085A1 Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis |
| 10/20/2004 | EP1468013A2 Conformationally constrained c-backbone cyclic peptides |
| 10/20/2004 | EP1468012A1 Biomolecule transduction motif mph-1-btm and the use thereof |
| 10/20/2004 | EP1468011A1 Biomolecule transduction motif sim-2-btm and the use thereof |
| 10/20/2004 | EP1468009A1 Peptide purification |
| 10/20/2004 | EP0959895B1 Peptides responsive to antibodies against a consensus peptide of the cs4-cfa/i family proteins |
| 10/20/2004 | EP0658113B1 Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof |
| 10/20/2004 | CN1171995C Assay for the diagnosis of schizophrenia based on a new peptide |
| 10/19/2004 | US6807421 Method for controlling connections to a mobile station |
| 10/19/2004 | US6806352 Nucleotide sequences coding membrane proteins/pro-polypeptides; anticarcinogenic/antitumor agents |
| 10/19/2004 | US6806255 Compounds and methods for modulating adhesion molecule function |
| 10/19/2004 | US6806053 Cell-signaling assays |
| 10/19/2004 | CA2238574C Targeted cytotoxic anthracycline analogs |
| 10/14/2004 | WO2004087754A1 Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between cd28 and the superantigen and uses thereof |
| 10/14/2004 | WO2004087744A2 Composition and method for nerve regeneration |
| 10/14/2004 | WO2004087742A2 Peptides for reducing symptoms of toxic shock syndrome and septic shck |
| 10/14/2004 | WO2004087734A2 Stq-peptides |
| 10/14/2004 | WO2004087196A2 Methods and compositions for the inhibition of modulation of t cell costimulatory pathway by a pathogenic agent |
| 10/14/2004 | WO2004011483A3 Isolated, ssx-2 and ssx-2 related peptides useful as hla binders and ctl epitopes, and uses thereof |
| 10/14/2004 | WO2003091395A3 Inhibition of immune complex formation |
| 10/14/2004 | WO2003089620A3 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 10/14/2004 | WO2001094377A3 Metalloprotease peptide substrates and methods |
| 10/14/2004 | US20040204561 Peptide aggregates |
| 10/14/2004 | US20040204367 Pipecolic acid derivatives of proline threonine amides useful for the treatment of rheumatoid arthritis |
| 10/14/2004 | US20040204348 Cyclic peptide ligands that target urokinase plasminogen activator receptor |
| 10/14/2004 | US20040204346 Intermediate for preparing glycopeptide derivatives |
| 10/14/2004 | US20040203000 Cell-signaling assays |
| 10/14/2004 | US20040202673 designed to elicit high level of antibodies for immunotherapy or immunomodulation of the body regulatory processes. |
| 10/14/2004 | US20040202659 A polypeptide encoded by a nucleic acid that encodes a heavy chain, which is able to bind to GPIIb/IIIa, of a human antibody and comprising a CDR3 region; diagnosis, treatment or prevention of autoimmune thrombocytopenic purpura; modulating blood coagulation |
| 10/14/2004 | US20040202650 Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA-4 specific antibodies |
| 10/14/2004 | CA2521047A1 Methods and compositions for the inhibition of modulation of t cell costimulatory pathway by a pathogenic agent |
| 10/14/2004 | CA2520789A1 Peptides for reducing symptoms of toxic shock syndrome and septic shock |
| 10/14/2004 | CA2520381A1 Proteolytic and covalent antibodies |
| 10/14/2004 | CA2520372A1 Stq-peptides |
| 10/13/2004 | EP1466614A1 Polypeptide, the conjugate thereof containing doxorubicine and a pharmaceutical composition based thereon |
| 10/13/2004 | EP1466179A1 Method for the diagnosis of cancers by measuring the changes of glycosylation of proteins related to tumorigenesis and metastasis and kit for diagnosis of cancers using the same |
| 10/13/2004 | EP1466178A1 Screening methods and the use of agents identified using the same |
| 10/13/2004 | EP1465918A2 Peptides promoting cell adherence, growth and secretion |
| 10/13/2004 | EP1465917A1 Intermediates for lhrh antagonist synthesis, process for their production, and process for lhrh antagonist production |
| 10/13/2004 | EP1465656A2 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR GnRH-I AND GnRH-II MODULATION OF T-CELL ACTIVITY, ADHESION, MIGRATION AND EXTRAVASATION |
| 10/13/2004 | EP1465649A2 Methods and compositions for derepression of iap-inhibited caspase |
| 10/13/2004 | EP1280820B1 Anti-inflammatory compounds and uses thereof |
| 10/13/2004 | EP1250095B1 Versatile hydrophilic dyes |
| 10/13/2004 | EP1203014B1 Peptide antagonists of factor viia |
| 10/13/2004 | EP0839155B1 CYSTEINE PROTEASE INHIBITORS FOR USE IN TREATMENT OF IgE MEDIATED ALLERGIC DISEASES |
| 10/13/2004 | EP0595838B1 Tumor rejection antigen precursors, tumor rejection antigens and uses thereof |